)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Wai Chun Bio-Technology
Wai Chun Bio-Technology (660) investor relations material
Wai Chun Bio-Technology H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary27 Feb, 2026
Executive summary
Revenue for the six months ended 31 December 2025 rose 118.7% year-over-year to HK$352.2 million, driven by increased market demand and consumption.
Gross profit increased to HK$35.7 million, but gross margin declined to 10.1% from 13.1% due to higher costs.
Loss attributable to owners narrowed to HK$5.9 million from HK$13.7 million year-over-year, mainly due to higher revenue and lower finance costs.
No interim dividend was declared for the period.
Financial highlights
Administrative expenses rose 22.8% to HK$14.9 million, mainly from higher staff costs.
Selling expenses surged 181.9% to HK$15.3 million, reflecting the revenue increase.
Finance costs dropped 51.4% to HK$5.0 million due to maturity and alteration of convertible bonds.
Net current liabilities improved to HK$61.2 million from HK$170.5 million as of 30 June 2025.
Cash and cash equivalents stood at HK$5.6 million at period end.
Outlook and guidance
Plans to pursue strategic acquisitions in the PRC to strengthen revenue and profit fundamentals.
Management is negotiating with potential investors and implementing cost controls to improve working capital and cash flows.
Actively identifying projects with growth potential for acquisitions or investments.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Wai Chun Bio-Technology
Next Wai Chun Bio-Technology earnings date
H2 202613 Nov, 2026
Wai Chun Bio-Technology
Next Wai Chun Bio-Technology earnings date
H2 202613 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company engaged in the trading and distribution of modified starch and other biochemical products. The company’s operations include sourcing, processing, and selling agricultural and industrial-grade starch products used in food processing, paper manufacturing, textiles, and other industrial applications. Wai Chun Bio-Technology also explores opportunities in related sectors to diversify its business portfolio. The company is headquartered in Hong Kong, and its shares are listed on the HKEX.